KALA - Kala Pharmaceuticals to execute reverse stock split

• Kala Pharmaceuticals ( NASDAQ: KALA ) will implement a reverse stock split of its common stock at a ratio of 1 post-split share for every 50 pre-split shares, effective at 4:05 p.m. on October 20, 2022.
• Every 50 shares of Kala’s ( KALA ) issued and outstanding common stock will be converted automatically into one issued and outstanding share of common stock without any change in the par value per share.
• The split will reduce the number of shares of common stock outstanding from 73,208,140 shares to ~1,464,163 shares, subject to adjustment for the rounding up of fractional shares.
• The stock will will begin trading on a split-adjusted basis when the market opens on Friday, October 21, 2022.
• KALA shares are down over 2% premarket

For further details see: